Charity Search / THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC
Diseases & Disorders (G50) IRS Verified DX Registered 990 on File

THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC

EIN: 06-1504413 · NORWALK, CT 06851-1544 · United States · FY 2025 Data
3 out of 5 59 / 100 Based on 2+ years of filings
Financial strength (30%) 94/100
Reliability (20%) 70/100
Effectiveness (25%) 88/100
Impact (25%) No data yet
Financial data: FY 2025 · Scored 10/18/2026
Register and add impact metrics to be rated above three stars
CharityAI™ Score
Not yet evaluated
Mission Statement

The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs.

Financial Overview — FY 2025
$36.5M
Total Revenue
$34.7M
Total Expenses
$48.0M
Net Assets
80
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio 78.9%
Fundraising Efficiency N/A
Operating Reserve 16.63x
Liability-to-Asset 23.6%
Revenue Diversification 72.9%
Executive Compensation $3.2M
Compared with Peers
FY 2025
Compared with 105 similar organizations (United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization Middle half of peers (P25–P75) Peer median
Ratio This org Peer median Position (P10 → P90)
Program expense ratio
Program expenses / total expenses · higher is better
78.9% 85.4%
P10P90
Below median
Admin expense ratio
Management and general / total expenses · lower is better
3.4% 11.1%
P10P90
Top quarter
Fundraising expense ratio
Fundraising expenses / total expenses · lower is better
17.6% 1.0%
P10P90
Bottom quarter
Operating reserve
Months of expenses covered by net assets · higher is better
16.6 mo 10.0 mo
P10P90
Above median
Liabilities to assets
Total liabilities / total assets · lower is better
23.6% 23.0%
P10P90
Below median
Revenue concentration
Share of revenue from the largest source · lower is better
72.9% 92.0%
P10P90
Top quarter
Revenue growth
Year over year revenue growth
25.5% 7.9%
P10P90
Expense growth
Year over year expense growth
-2.7% 7.8%
P10P90
Surplus margin
Surplus as a share of revenue
5.1% 3.2%
P10P90
Financial History
Year Revenue Expenses Net Assets Program % Staff
2025 $36.5M $34.7M $48.0M 78.9% 80
2024 $29.1M $35.6M $50.0M 81.5% 72
2023 $34.0M $41.9M $56.3M 83.5% 78
2022 $45.0M $38.3M $63.7M 84.2% 80
2021 $42.3M $37.6M N/A — 74
Donor Reviews
Write a Review
No reviews yet

Be the first to share your experience with this organization.


Write a Review
Minimum 20 characters
Reviews appear after moderation (usually within 24 hours)
Organization Details
EIN
06-1504413
State
CT
City
NORWALK
ZIP
06851-1544
Classification
G50
Category
Diseases & Disorders
Rating
3★
Coverage
A
Last Updated
Aug 2026
IRS Ruling Year
Foundation Code
15
Form 990
On File
Is this your organization?

Claim it to manage this profile, add your board, financials and impact metrics, and lift your CharityAI™ rating.

Claim this Charity
Back to Search New Search